It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

TOPEKA (KSNT) – December is a peak month for the spread of respiratory syncytial virus, or RSV, a respiratory virus that causes mild cold-like symptoms and poses a special risk for babies and older ...

According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...

TikTok, X, and Instagram are flooded with videos about a mysterious “2025 throat virus” that’s making everyone sick. The ...

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

An experts' panel at the Ministry of Health, Labor and Welfare convenes a meeting to discuss vaccination against respiratory syncytial virus on Nov. 19, 2025, in Tokyo. (Kyodo) TOKYO (Kyodo) -- Japan ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Some of the warning signs may be similar to the flu or common cold ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

A pediatric emergency medicine physician reveals the symptoms you should be watching for—and the four viruses responsible.

Nearly all adults carry Epstein–Barr virus—but new research reveals how it can hijack immune cells, sparking a chronic disease that attacks the body from within. This colorized transmission electron ...

RSV vaccines showed initial high effectiveness, but protection decreased over 18 months, especially in immunocompromised individuals. The study used VHA data to evaluate vaccine effectiveness in ...